Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin).

[1]  G. Cioffi,et al.  Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. , 2009, JACC. Cardiovascular imaging.

[2]  J. Després,et al.  Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease , 2009, Hypertension.

[3]  M. Worthley,et al.  Obesity is associated with impaired human coronary endothelial function. , 2009, Obesity research & clinical practice.

[4]  N. Wong,et al.  Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression , 2009, Diabetes.

[5]  F. Lopez‐Jimenez,et al.  Abnormal cardiac structure and function in the metabolic syndrome: a population-based study. , 2008, Mayo Clinic proceedings.

[6]  A. Akki,et al.  Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy. , 2008, Cardiovascular research.

[7]  R. Devereux,et al.  Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[8]  M. Picard,et al.  A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload. , 2008, American journal of physiology. Heart and circulatory physiology.

[9]  Davinder S Jassal,et al.  Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  Mario J. Garcia,et al.  Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. , 2008, The Annals of thoracic surgery.

[11]  J. Knuuti,et al.  Myocardial fatty acid metabolism and cardiac performance in heart failure , 2008, Current cardiology reports.

[12]  A. Akki,et al.  Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation , 2008, Molecular and Cellular Biochemistry.

[13]  V. Positano,et al.  Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat , 2008, Hypertension.

[14]  G. Lopaschuk,et al.  Cardiac Energy Metabolism in Obesity , 2007, Circulation research.

[15]  K. Teo,et al.  Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. , 2007, American heart journal.

[16]  Victor M Montori,et al.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.

[17]  G. Lopaschuk,et al.  Alterations in energy metabolism in cardiomyopathies , 2007, Annals of medicine.

[18]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[19]  J. Després,et al.  Metabolic Syndrome Is Associated With Faster Degeneration of Bioprosthetic Valves , 2006, Circulation.

[20]  J. Després,et al.  Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. , 2006, Journal of the American College of Cardiology.

[21]  R. Kronmal,et al.  Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis , 2006, Circulation.

[22]  B. Pannier,et al.  Metabolic syndrome and age-related progression of aortic stiffness. , 2006, Journal of the American College of Cardiology.

[23]  Damien Garcia,et al.  Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. , 2005, Journal of the American College of Cardiology.

[24]  R. Gropler,et al.  Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. , 2004, Journal of the American College of Cardiology.

[25]  G. Lopaschuk.  Metabolic Abnormalities in the Diabetic Heart , 2002, Heart Failure Reviews.

[26]  Yuling Hong,et al.  Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study , 2002, Journal of hypertension.

[27]  M. Schemper,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis. , 2000, The New England journal of medicine.

[28]  J. Laragh,et al.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. , 1995, Journal of the American College of Cardiology.

[29]  G. Aurigemma,et al.  Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis. , 1994, The American journal of cardiology.

[30]  G. Aurigemma,et al.  Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. , 1993, Journal of the American College of Cardiology.

[31]  J. Laragh,et al.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.

[32]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[33]  J. Dumesnil,et al.  Effect of the Geometry of the Left Ventricle on the Calculation of Ejection Fraction , 1982, Circulation.

[34]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[35]  B. Howard,et al.  Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). , 2004, The American journal of cardiology.

[36]  R. Unger,et al.  Lipotoxic diseases. , 2002, Annual review of medicine.

[37]  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.

[38]  P. Poirier,et al.  Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. , 2001, Diabetes care.